期刊文献+

甲磺酸托烷司琼含量测定

Content Determination of Methanesulfonic Acid Tropisetron
下载PDF
导出
摘要 目的:建立高效液相色谱法对甲磺酸托烷司琼注射液进行含量测定。方法:色谱柱为Kromasil 100-5C18(250 nm×4.6 nm,5μm),以甲醇-水-乙腈-三乙胺(750:200:50:0.2)为流动相;流速为1.0 ml/min;检测波长为284nm。结果:甲磺酸托烷司琼检测量在1.6~2.4μg范围内,与色谱峰面积线性关系良好,Y=2 547.2X+3.456,r=1;准确度试验中回收率为99.99%(RSD=0.51%,n=9)。结论:本文建立的含量测定方法快速、准确、重现性好,含量测定HPLC检查方法专属性强、灵敏度高,可用于甲磺酸托烷司琼注射液的质量控制。 Objective:To establish the content determination method of methanesulfonic acid tropisetron injecta through HPLC.Method: Chromatographic column: Kromasil 100-5C18(250 nm×4.6 nm,5 μm),mobile: the mixture of methanol,water,acetonitrile,triethylamine(750:200:50:0.2, V/V/V/V);flow rate: 1.0 ml/min;detection: 284 nm.Result: The linear relation of chromatographic peak area was better in the detection extent from 1.6 to 2.4 μg,which was Y=2 547.2X+3.456,r=1;the recovery was 99.9%(RSD=0.51%,n=9) in accuracy experiment.Conclusion:The test method established is applied to quality control in methanesulfonic acid tropisetron injecta which is characterized by quick,accurate,well in repeatability,high HPLC specificity and sensitive.
出处 《沈阳医学院学报》 2012年第2期96-97,共2页 Journal of Shenyang Medical College
关键词 甲磺酸托烷司琼 含量测定 高效液相色谱法 methanesulfonic acid tropisetron; content determination; high performance liquid chromatography
  • 相关文献

参考文献2

二级参考文献7

  • 1[1]Sorbe BG,Hogberg T,Glimelius B,et al.A randomized,multicenter study comparing the efficacy and tolerability of tropisetron,a new 5-HT3 receptor antagonist,with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis[J].Cancer,1994,73(2)∶445-454.
  • 2[2]Sorbe B,Andersson H,Schmidt M,et al.Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting-the Nordic experience[J].Support Care Cancer,1994,2(6)∶393-399.
  • 3[3]Marty M,Kleisbauer JP,Fournel P,et al.Is Navoban (tropiset-ron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? The French Navoban Study Group[J].Anticancer Drugs,1995, 6 (Suppl 1)∶S15-S21.
  • 4[4]Bruntsch U,Drechsler S,Eggert J,et al.Prevention of chemoth-erapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents[J].Semin Oncol,1994,21(5 Suppl 9)∶S7-S11.
  • 5[5]Madej G,Krzakowski M,Pawinski A,et al.A report comparing the useof tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis[J].Semin Oncol,1994,21(5 Suppl 9)∶S3-S6.
  • 6[6]Sorbe BG .Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience[J].Semin Oncol,1994,21(5 Suppl 9)∶S20-S26.
  • 7[7]Sorbe B,Hallen C,Frankendal B .An open,randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis[J].Cancer Chemother Pharmacol,1994,33(4)∶298-302.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部